Carvedilol Patent Expiration
Carvedilol is Used for reducing mortality associated with congestive heart failure. It was first introduced by Waylis Therapeutics Llc
Carvedilol Patents
Given below is the list of patents protecting Carvedilol, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Coreg |
USRE40000 (Pediatric) | Method of treatment for decreasing mortality resulting from congestive heart failure |
Dec 07, 2015
(Expired) | Waylis Therap |
Coreg | USRE40000 | Method of treatment for decreasing mortality resulting from congestive heart failure |
Jun 07, 2015
(Expired) | Waylis Therap |
Carvedilol's Family Patents

Explore Our Curated Drug Screens
Carvedilol Generic API Manufacturers
Several generic applications have been filed for Carvedilol. The first generic version for Carvedilol was by Teva Pharmaceuticals Usa Inc and was approved on Sep 5, 2007. And the latest generic version is by Mlv Pharma Llc and was approved on Dec 22, 2009.
Given below is the list of companies who have filed for Carvedilol generic, along with the locations of their manufacturing plants worldwide.
1. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Carvedilol. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
3.125MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
6.25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
12.5MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
India |
| |||||||||
United States |
|
2. BEXIMCO USA
Beximco Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Carvedilol. Given below are the details of the strengths of this generic introduced by Beximco Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
3.125MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
6.25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
12.5MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
3. CHARTWELL MOLECULAR
Chartwell Molecular Holdings Llc has filed for 4 different strengths of generic version for Carvedilol. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
3.125MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
6.25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
12.5MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
4. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Carvedilol. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
3.125MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
6.25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
12.5MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
5. GRAVITI PHARMS
Graviti Pharmaceuticals Private Ltd has filed for 4 different strengths of generic version for Carvedilol. Given below are the details of the strengths of this generic introduced by Graviti Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
3.125MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
6.25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
12.5MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
6. HIKMA
Hikma Pharmaceuticals has filed for 4 different strengths of generic version for Carvedilol. Given below are the details of the strengths of this generic introduced by Hikma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
3.125MG | tablet | Discontinued | ORAL | N/A | Sep 7, 2007 |
6.25MG | tablet | Discontinued | ORAL | N/A | Sep 7, 2007 |
12.5MG | tablet | Discontinued | ORAL | N/A | Sep 7, 2007 |
25MG | tablet | Discontinued | ORAL | N/A | Sep 7, 2007 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||
Portugal |
| |||||||||
Jordan |
|
7. LUPIN
Lupin Ltd has filed for 4 different strengths of generic version for Carvedilol. Given below are the details of the strengths of this generic introduced by Lupin.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
3.125MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
6.25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
12.5MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
Manufacturing Plant Locations New
Lupin's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Lupin as present at those locations.
Country | City | Firm Name | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
| |||||||||||||||||||||||||||||
United States |
|
8. MLV
Mlv Pharma Llc has filed for 4 different strengths of generic version for Carvedilol. Given below are the details of the strengths of this generic introduced by Mlv.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
3.125MG | tablet | Prescription | ORAL | AB | Dec 22, 2009 |
6.25MG | tablet | Prescription | ORAL | AB | Dec 22, 2009 |
12.5MG | tablet | Prescription | ORAL | AB | Dec 22, 2009 |
25MG | tablet | Prescription | ORAL | AB | Dec 22, 2009 |
9. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 4 different strengths of generic version for Carvedilol. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
3.125MG | tablet | Discontinued | ORAL | N/A | Sep 5, 2007 |
6.25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
12.5MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
10. PLIVA HRVATSKA DOO
Pliva Hrvatska Doo has filed for 4 different strengths of generic version for Carvedilol. Given below are the details of the strengths of this generic introduced by Pliva Hrvatska Doo.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
25MG | tablet | Discontinued | ORAL | N/A | Oct 30, 2007 |
3.125MG | tablet | Discontinued | ORAL | N/A | Oct 30, 2007 |
6.25MG | tablet | Discontinued | ORAL | N/A | Oct 30, 2007 |
12.5MG | tablet | Discontinued | ORAL | N/A | Oct 30, 2007 |
11. RUBICON
Rubicon Research Private Ltd has filed for 4 different strengths of generic version for Carvedilol. Given below are the details of the strengths of this generic introduced by Rubicon.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
3.125MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
6.25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
12.5MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
Manufacturing Plant Locations New
Rubicon's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Rubicon as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
United States |
| |||||
Canada |
| |||||
India |
|
12. SANDOZ
Sandoz Inc has filed for 4 different strengths of generic version for Carvedilol. Given below are the details of the strengths of this generic introduced by Sandoz.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
3.125MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
6.25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
12.5MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
Manufacturing Plant Locations New
Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
Austria |
| |||||
United States |
| |||||
Spain |
| |||||
India |
|
13. SUN PHARM INDS INC
Sun Pharmaceutical Industries Inc has filed for 4 different strengths of generic version for Carvedilol. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
6.25MG | tablet | Discontinued | ORAL | N/A | Sep 5, 2007 |
12.5MG | tablet | Discontinued | ORAL | N/A | Sep 5, 2007 |
25MG | tablet | Discontinued | ORAL | N/A | Sep 5, 2007 |
3.125MG | tablet | Discontinued | ORAL | N/A | Sep 5, 2007 |
14. SUN PHARM INDS LTD
Sun Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Carvedilol. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
3.125MG | tablet | Discontinued | ORAL | N/A | Sep 5, 2007 |
6.25MG | tablet | Discontinued | ORAL | N/A | Sep 5, 2007 |
12.5MG | tablet | Discontinued | ORAL | N/A | Sep 5, 2007 |
25MG | tablet | Discontinued | ORAL | N/A | Sep 5, 2007 |
15. TARO
Taro Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Carvedilol. Given below are the details of the strengths of this generic introduced by Taro.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
3.125MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
6.25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
12.5MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
Manufacturing Plant Locations New
Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
United States |
| |||||
Israel |
| |||||
Canada |
|
16. TEVA
Teva Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Carvedilol. Given below are the details of the strengths of this generic introduced by Teva.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
3.125MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
6.25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
12.5MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
Manufacturing Plant Locations New
Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||
India |
| |||||||||
Canada |
| |||||||||
Czech Republic |
| |||||||||
Ireland |
| |||||||||
Israel |
|
17. ZYDUS PHARMS USA INC
Zydus Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Carvedilol. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
6.25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
12.5MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
25MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |
3.125MG | tablet | Prescription | ORAL | AB | Sep 5, 2007 |